Newsroom
Sorted by: Latest
-
Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets
SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced expanded regulatory and clinical trial services to international pharmaceutical and medical device companies seeking a streamlined path into European, including the United Kingdom and Switzerland, plus Australian, Canadian, and U.S. markets. Particularly, Veristat has helped many Chinese companies – including Hansoh Pharma and CStone Pharmaceut...
-
Sprinklr Announces Fourth Quarter and Full Year Fiscal 2026 Results
NEW YORK--(BUSINESS WIRE)--Sprinklr Announces Fourth Quarter and Full Year Fiscal 2026 Results...
-
Verituity Advances Confidence-Based Verification at the Point of Payout
MCLEAN, Va.--(BUSINESS WIRE)--Verituity announces an expansion of its verification framework with confidence-based Payment Method Verification at the point of payout....
-
Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it has received two Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent applications relating to the Company’s PBGENE-HBV program. The first Notice of Allowance relates to U.S. Patent Application No. 19/347,136, tit...
-
Predictable Power: StandardAero Selected by Robinson Helicopter Company as Preferred MRO Provider for R66 Rolls-Royce RR300 Engines
SCOTTSDALE, Ariz. & TORRANCE, Calif.--(BUSINESS WIRE)--StandardAero (NYSE: SARO), a leading independent pure-play provider of aerospace engine aftermarket services including engine maintenance, repair and overhaul (MRO) and engine component repair, has been selected by U.S. helicopter OEM, Robinson Helicopter Company, to support their global fleet of R66 helicopters powered by the Rolls-Royce RR300 engine. This relationship will provide R66 helicopter owners and operators with a Robinson-recomm...
-
Smith Douglas Homes Reports Fourth Quarter and Full Year 2025 Results
ATLANTA--(BUSINESS WIRE)--Smith Douglas Homes Corp. (NYSE: SDHC) (“Smith Douglas” or the “Company”) today announced results for the fourth quarter and year ended December 31, 2025. Q4 2025 Results as compared to Q4 2024: Home closings decreased 7% to 780 Home closing revenue decreased 9% to $260.4 million Home closing gross margin of 19.9% compared to 25.5% Net new home orders decreased 7% to 532 Pre-tax income of $16.9 million compared to $30.0 million Earnings of $0.39 per diluted share Full...
-
Swarm Aero Announces $35M Series A Financing Led by Two Sigma Ventures and Silent Ventures
OXNARD, Calif.--(BUSINESS WIRE)--Swarm Aero announces $35M Series A financing to accelerate the development and deployment of the company’s large UAV and swarm software....
-
Virtus Investment Partners Reports Preliminary February 28, 2026 Assets Under Management
HARTFORD, Conn.--(BUSINESS WIRE)--Virtus Investment Partners, Inc. (NYSE: VRTS) today reported preliminary assets under management (AUM) of $155.9 billion and other fee earning assets of $1.7 billion for total client assets of $157.6 billion as of February 28, 2026. The change in AUM from January 31, 2026 reflects net outflows in institutional accounts, retail separate accounts, and U.S. retail funds, partially offset by market performance and positive net flows in exchange-traded funds and glo...
-
Phenom Announces 2026 HR Award Winners: Enterprises Set New Performance Benchmarks with Applied AI
PHILADELPHIA--(BUSINESS WIRE)--Phenom Announces 2026 HR Award Winners: Enterprises Set New Performance Benchmarks with Applied AI...
-
NASA Awards Redwire $4 Million In Additional Funding to Support Trailblazing Drug Development in Microgravity
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract...